Literature DB >> 29079891

Parent Perspectives of Support Received from Physicians and/or Genetic Counselors Following a Decision to Continue a Pregnancy with a Prenatal Diagnosis of Trisomy 13/18.

Stephanie E Wallace1, Sara Gilvary2, Michael J Smith2, Siobhan M Dolan2,3.   

Abstract

Families that choose to continue a pregnancy with a prenatal diagnosis of Trisomy 13/18 are a minority that present unique challenges for those in charge of their care. This study investigated the extent to which these patients felt supported by their healthcare providers, and any differences in the perceived level of support experienced by those working with a physician versus those working with a genetic counselor. Two online support groups, SOFT and Hope for Trisomy, distributed an online survey to their members. Means, standard deviations and chi-square analysis were calculated to describe their responses. One-hundred fourteen surveys were included in the final analysis. Respondents were more likely to agree that genetic counselors provided unbiased information in a way that they understood, compared to physicians. Review of qualitative responses found that portrayal of Trisomy 13/18 by healthcare providers used directive language when describing the lethality, morbidity and burden of the condition. Language included terms such as "incompatible with life" and comments on burden to other family members. Healthcare providers can assist families that receive a prenatal diagnosis of Trisomy 13 or 18 by providing up-to-date written resources and connecting them with support groups for parents who have received a similar diagnosis. Our study found that involving genetic counselors in the prenatal care of these patients is likely beneficial.

Entities:  

Keywords:  Genetic counselor; Patient support; Prenatal diagnosis; Termination of pregnancy; Trisomy 13; Trisomy 18

Mesh:

Year:  2017        PMID: 29079891     DOI: 10.1007/s10897-017-0168-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  28 in total

1.  A Methodology for Conducting Integrative Mixed Methods Research and Data Analyses.

Authors:  Felipe González Castro; Joshua G Kellison; Stephen J Boyd; Albert Kopak
Journal:  J Mix Methods Res       Date:  2010-09-20

2.  Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years.

Authors:  Claire Irving; Sam Richmond; Christoper Wren; Caitlin Longster; Nicholas D Embleton
Journal:  J Matern Fetal Neonatal Med       Date:  2010-04-12

3.  Population-based analyses of mortality in trisomy 13 and trisomy 18.

Authors:  Sonja A Rasmussen; Lee-Yang C Wong; Quanhe Yang; Kristin M May; J M Friedman
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  The experience of families with children with trisomy 13 and 18 in social networks.

Authors:  Annie Janvier; Barbara Farlow; Benjamin S Wilfond
Journal:  Pediatrics       Date:  2012-07-23       Impact factor: 7.124

5.  Natural history of fetal trisomy 13 after prenatal diagnosis.

Authors:  Sinead C Barry; Colin A Walsh; Annette L Burke; Peter McParland; Fionnuala M McAuliffe; John J Morrison
Journal:  Am J Med Genet A       Date:  2014-10-22       Impact factor: 2.802

6.  The decision to continue: the experiences and needs of parents who receive a prenatal diagnosis of holoprosencephaly.

Authors:  Krista Redlinger-Grosse; Barbara A Bernhardt; Kate Berg; Maximilian Muenke; Barbara B Biesecker
Journal:  Am J Med Genet       Date:  2002-11-01

7.  Responsibly counselling women about the clinical management of pregnancies complicated by severe fetal anomalies.

Authors:  Frank Chervenak; Laurence B McCullough
Journal:  J Med Ethics       Date:  2012-02-13       Impact factor: 2.903

8.  An ethically justified practical approach to offering, recommending, performing, and referring for induced abortion and feticide.

Authors:  Frank A Chervenak; Laurence B McCullough
Journal:  Am J Obstet Gynecol       Date:  2009-09-17       Impact factor: 8.661

9.  Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk.

Authors:  B J Baty; B L Blackburn; J C Carey
Journal:  Am J Med Genet       Date:  1994-01-15

10.  Maternal age-specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age.

Authors:  Young Joo Kim; Jee Eun Lee; Soo Hyun Kim; Sung Shin Shim; Dong Hyun Cha
Journal:  Obstet Gynecol Sci       Date:  2013-05-16
View more
  2 in total

1.  Is preparation a good reason for prenatal genetic testing? Ethical and critical questions.

Authors:  Marsha Michie
Journal:  Birth Defects Res       Date:  2020-03-01       Impact factor: 2.344

2.  Opportunities and pitfalls of social media research in rare genetic diseases: a systematic review.

Authors:  Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley
Journal:  Genet Med       Date:  2021-07-19       Impact factor: 8.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.